Estadístiques de Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer
Visites totals
| views | |
|---|---|
| Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer | 13 |
Visites totals per mes
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 9 |
| September 2024 | 1 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 1 |
| January 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Fiascarelli_bcrt_anti.pdf(legacy) | 3 |
| Fiascarelli_bcrt_anti.pdf | 2 |
Vistes principals per país
| views | |
|---|---|
| United States | 9 |
| Belgium | 3 |
| China | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Menlo Park | 9 |